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Résumé 
Objectif: Le syndrome de vasoconstriction cérébrale réversible (SVCR) est une entité 
clinico-radiologique associant des céphalées paroxystiques à un vasospasme uni- ou 
multifocal réversible des artères cérébrales avec ou sans déficit neurologique transitoire 
ou crise comitiale. Le but de notre étude est de rechercher les facteurs de mauvais 
pronostic des patients présentant un SVCR. 
Méthode : Nous avons réalisé une étude rétrospective des imageries vasculaires 
cérébrales invasives et non invasives entre janvier 2006 et 2011 et avons retenu 10 
patients présentant les critères du RCVS. Les données démographiques, facteurs de 
risque vasculaires ainsi que l'évolution de chaque patient ont été noté. 
Résultats : Sept des 10 patients sont des femmes, avec un âge médian de 46 ans. Quatre 
patients ne présentaient pas de facteur étiologique, deux femmes se trouvaient en 
période post-partum (entre la première et la troisième semaine) et les trois autres cas 
sont induits par des drogues vaso-àctives (cannabis pour 2 cas dont un associé à la 
cyclosporine, sumatriptan pour un cas). La durée moyenne du suivi est de 10,2 mois (0-
28 mois). Deux patients ont présentés une séquelle neurologique: un a gardé des 
troubles phasiques et l'autre une hémianopsie latérale homonyme. Deux autres patients 
sont décédés dans les suites, ce qui est inhabituel. Nous n'avons pas trouvé de 
corrélation d'évolution différente entre les cas de SVCR primaire ou secondaire. Les 
seules facteurs corrélaient à l'évolution clinique sont le status neurologique à 
l'admission et la présence de lésion parenchymateuse (ischémie ou hématome) à 
l'imagerie. 
Conclusion : La vasoconstriction cérébrale réversible impliquant des déficits 
neurologiques ou la mort a été, rarement, rapportée. Nous devons garder à l'esprit 
qu'une telle évolution peut survenir notamment pour les cas présentant un état 
neurologique dégradé à l'admission ou présentant des lésions parenchymateuses à 
l'imagerie. 
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1. Introduction 
ABSTRACT 
Object: : Reversible cerebral vasoconstriction syndrome (RCVS) is described as a clinical and radiological 
entity characterized by thunderclap headaches, a reversible segmental or multifocal vasoconstriction of 
cerebral arteries with or without focal neurological deficits or seizures. The purpose of this study is to 
determine risk factors of poor outcome in patients presented a RCVS. 
Methods: A retrospective multi-center review of invasive and non-invasive neurovascular imaging 
betweenjanuary 2006 andjanuary 2011 has identified 10 patients with criterion ofreversible segmental 
vasoconstriction syndrome. Demographics data, vascular risks and evolution of each of these patients 
were analyzed. 
Results: Seven of the ten patients were females with a mean age of 46 years. In four patients, we did not 
found any causative factors. Two cases presented RCVS in post-partum period between their first and 
their third week after delivery. The other three cases were drug-induced RCVS, mainly vaso-active drugs. 
Cannabis was found as the causative factor in two patient, Sumatriptan identified in one patient while 
cyclosporine was the causative agent in also one patient. The mean duration of clinical follow-up was 
10.2 months (range: 0-28 months). Two patients had neurological sequelae: one patient kept a dysphasia 
and the other had a homonymous lateral hemianopia. We could not find any significant difference of the 
evolution between secondary RCVS and idiopathie RCVS. The only two factors, which could be correlated 
to the clinical outcome were the neurological status at admission and the presence of intraparenchymal 
abnormalities (ischemic stroke, hematoma) in brain imaging. 
Conclusions: Fulminant vasoconstriction resulting in progressive symptoms or death has been reported 
in exceptional frequency. Physicians had to remember that such evolution could happen and predict 
them by identifying ail factors of poor prognosis (neurological status at admission, the presence of 
intraparenchymal abnormalities ). 
Published by Elsevier B.V. 
Reversible cerebral vasoconstriction syndrome (RCVS) has been 
proposed as a unifying term for a variety of similar syndromes 
[1,2] including Cali-Fleming syndrome [3], benign angiopathy of 
the central nervous system [4], postpartum cerebral angiopathy 
[ 5], migrai nous vasospasm, thunderclap headaches with reversible 
vasospasm and drug-induced angiopathy [6]. RCVS is described 
as a clinical and radiological entity characterized by thunderclap 
headaches, a reversible segmental or multifocal vasoconstriction 
of cerebral arteries with or without focal neurological deficits or 
seizures [ 1,6-8 ]. 
Abbreviations: RCVS, reversible cerebral vasoconstriction syndrome: CT, 
computerized tomography; CTA, computerized tomographie angiography; MRI, 
magnetic resonance imaging; MRA, magnetic resonance angiography; OSA, digital 
subtraction angiography; SAH, subarachnoïd hemorrhage: AVM, arteriovenous mal-
formation; CSF, cerebrospinal fluid; HLH, homonymous lateral hemianopia; mRS, 
modified Rankin score. 
* Corresponding author. Present addr~ss: Department of Interventional Neurora-
diology, Fondation Rothschild, 25 Rue Manin, 75019 Paris, France. 
E-mail address: tl1ornas.robert43Q'Ogrnail.com (Th. Robert). 
0303-8467 /$ - see front matter. Published by Elsevier B.V. 
http://dx.doi.org/ 10.10JG/j.clineuro.2013.08.014 
Approximately, 60% of cases are secondary to a known etiology 
[9]; the most frequently inferred ones are exposure to vasoactive 
drugs such as serotonergics [ 9-13], sympathomimetics [ 14-16] 
and chemotherapeutics [18,19], some clinical states such as preg-
nancy [20-24] and puerperium [25 ]. RCVS has a middle-aged 
female preponderance [ 1,3,6-9,26-31 ]. The most common clini-
cal feature of RCVS is a severe acute headache [6,9] presented as 
thunderclap headache, often accompanied by nausea, vomiting, 
photophobia, blurred vision and transient motor deficit [7,32-34]. 
Neurovascular imaging( conventional cerebral angiography ornon-
invasive imaging) typically shows diffuse, multifocal, segmental 
narrowing involving large and medium-sized arteries with strings 
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and bead appearance [6-9,35-37]. These radiological abnormali-
ties disappeared spontaneously or in response to calcium-channel 
blockers in a delay of 2-3 weeks [1,7,38]. Despite the reversibil-
ity of angiographie signs, RCVS could be complicated by ischemic 
stroke [7-9,38-40] or convexity subarachnoid hemorrhage [ 1,7,8]. 
These complications are rare and without identified precipitating 
factors. 
Recent literature reflected the growing interest for RCVS. 
Approximately 75 isolated cases are described between 1992 and 
2011. However, only two studies [ 6] including more than ten cases 
have been published. The combination of more frequent cere-
brovascular imaging with non-invasive techniques and the use of 
vaso-active drugs put a growing number of patients within RCVS 
spectrum. Complications and prognostic factors of RCVS were not 
developed in published studies. 
We present our experience on reversible cerebral vasocon-
striction syndrome with ten consecutive cases of angiographically 
proven RCVS, which were diagnosed between the university hos-
pital of Lausanne and the regional hospital of Sion. Two patients 
in our study developed fatal complications; we discuss prognostic 
factors of RCVS in light of a review of the literature. 
2. Patients and methods 
We retrospectively reviewed invasive and non-invasive neu-
rovascular imaging performed in our medical centers between 
january 2006 and january 2011 in the radiological database. 318 
patients were selected who presented cerebral vasospasm. We 
excluded ail patients with a history of cerebral aneurysm and other 
cerebro-vascular malformations (282 patients). We also excluded 
patients without documentation of the reversibility of neurovas-
cular abnormalities (287 patients). After the exclusion criteria, 10 
patients were identified as presenting a reversible cerebral vaso-
constriction syndrome and satisfying the three diagnostic criteria 
for RCVS: (i) unusual, severe headaches with or without focal neu-
rological deficit or seizures; (ii) cerebral vasoconstriction assessed 
by computerized tomographyangiography (CTA), magnetic res-
onance angiography (MRA) or conventional digital subtraction 
angiography (DSA) with at leasttwo different arteries involved; (iii) 
reversibility ofradiological abnormalities in less than three months 
from the initial event (Fig. 1 ). 
The following data were collected: age, sex, history ofheadache, 
blood pressure, vaso-active drug, history of postpartum period, 
Fig. 1. Typical neuro-imaging features ofreversible cerebral vasoconstriction syndrome. Axial computerized tomography (a) showed a capsular hematoma with mass effect. 
Corona! fluid attenuated inversion recove1y (FLAIR) MR scan (b) with ischemia in the territory of the anterior cerebral artery. Right vertebral (c) and right internai carotid 
artery ( d) digital subtraction angiography with Jateral views demonstrating multifocal vasoconstrictions of large and middle-size arteries. 
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Table 1 
Demographic data. 
Total (11=10) Males (n =3) Females (11=7) 
Age 
His tory of hypertension 
His tory of migraine 
Single thunderclap headache 
Recurrent thunclerclap headache 
Vasoactive substances 
Postpartum period 
46(23-68) 
60% (n=6) 
30% (n=3) 
10%(n=1) 
90% (11=9) 
40% (11=4) 
20%(11=2) 
48 (39-64) 
33%(11=1) 
33%(11=1) 
0%(n=O) 
100%(11=3) 
0%(n=O) 
39(23-68) 
71% (n =5) 
28% (11 =2) 
14% (11=1) 
86% (Il =6) 
57% (11=4) 
29% (n =2) 
focal neurological deficits, seizures, associated-subarachnoid hem-
orrhage (SAH), radiological and clinical evolution with the modified 
Ranking score (mRs). We also recorded the evidence of complica-
tions: ischemic stroke, intra-cerebral hemorrhage. 
Ali patients benefited neurovascular imaging at admission and 
after two weeks offollow-up. A lumbar puncture was performed in 
all patients to exclude differential diagnoses of primary angiitis of 
the central nervous system ( CNS). A clinical and radiological follow-
up by MRA or CTA was performed in all patients at 3 months of 
discharge. 
No standard treatment protocol was used. 
2.1. Statistics 
Descriptive statistics are presented as mean and standard 
deviation or as frequency and percent. Multi-variant analysis of 
prognostic factors is performed for each patient. 
3. Results 
3.1. Demograp/Jics and patients past medical /Jistories 
The demographic data of the 10 patients are indicated in Table 1. 
Seven of the ten patients were female; their ages ranged from 
23 to 68 years with a mean age of 46 years. Six patients (60%) 
had a history of hypertension. Other chronic medical conditions 
included depression, diabetes mellitus and hypercholesterolemia. 
Five patients presented a history of primary headaches disorders 
or migraine. Two patients did not have any relevant past medical 
history. 
One of the patients had a history of arterio-venous malforma-
tion (AVM). Itwas an occipital AVM grade Spetzler-Martin 3 which 
was treated 11 years before by endovascular treatment and surgi-
cal resection. He also had a right postero-inferior cerebellar artery 
(PICA) aneurysm treated 10 years before by endovascular coiling. 
There was no persona! or family history of migraine, no particular 
medication at admission and no history of drugs abuse. Neurologi-
cal examination revealed isolated right homonymous hemianopia 
with no altered level of consciousness and no motor deficit. A cere-
bral computerized tomography (CT) with angiographie sequences 
( CT A) at admission showed a left cortical subarachnoid hemorrhage 
(SAH) without any vascular etiology. Regarding neuro-vascular his-
tory of the patient, a cerebral angiography was performed, which 
revealed diffuse cerebral vasoconstriction without finding the eti-
ology of the SAH (there was no new aneurysm, no residual AVM). 
Cerebrospinal fluid (CSF) examination including autoimmune anti-
body was normal. A repeated CT angiography 3 months later was 
entirely normal and demonstrated that cerebral vasoconstriction 
completely disappeared which was the proof of the reversibility of 
the patient's condition. 
3.2. Riskfactors 
We classîfied RCVS as secondary (post partum period or drug-
induced vasospasm) or as idiopathie. In four patients, we did not 
found any causative factors. Two cases presented RCVS in post 
partum period between their first and their third week after the 
delivery. The other four cases were drug-induced RCVS. Vasa-active 
substances used were cannabis (two patients), sumatriptan (one 
patient) and cyclosporine (one patient). The se data are summarized 
in Tables 1 and 2. 
3.3. Headac/Jes c/Jaracteristics 
On average, patients presented 4 (from 1 to 6) thunderclap 
headache attacks during the disease course. The median duration 
of thunderclap headache attacks was 30 min. The headaches were 
described as explosive at onset then throbbing. Headache was gen-
erally bila te ra! (90%). Nausea and vomiting were the most common 
associated symptoms (70%). The headaches completely disap-
peared at a mean of 17 days (two dead patients were excluded). 
The blood pressure of each patient was noted at the first exami-
nation and 70% (7 patients) presented an elevated blood pressure 
(systolic upper than 140 or diastolic upper than 90) at admission. 
We have noticed that all patient with a mRS 0 at 3 months had had 
no elevated blood pressure at presentation but the difference was 
not statically significant. 
3.4. Ot/Jer neuro/ogical symptoms 
Eight patients (80%) had other neurological symptoms. Seven 
patients (70%) presented focal neurological deficit, which was 
rapidly reversible in six patients. Visual symptoms were the most 
frequent, followed by hemiparesis and aphasia. Two patients also 
presented confusion at admission. Other two patients presented 
generalized tonico-clonic seizures which have been controlled by 
antiepileptic drugs. 
Two patients (20%) had persistent deficits due to ischemic stroke 
(case 2 and 3). The first one was a young woman who presented 
bifrontal ischemic stroke five days after admission, secondary to 
a bilateral anterior cerebral arteries vasospasm. After a comatose 
state during 12 days, she died unfortunately. The other one was 
also a woman who presented diffuse cerebral vasospasm inter-
esting both anterior and posterior circulations. Three days after 
her admission, she developed multifocal ischemic stroke in both 
hemispheres and died 13 days later. 
3.5. Neurovascular imaging 
All patients had a cerebral CT scan without angio-CT as the first 
imaging investigation. This initial CT was performed at a me an of 2 
days after the onset of the headache and was abnormal in 4 patients 
(two patients presented convexity SAH, one patient an ischemic 
stroke and other the both). Between the five patients who pre-
sented a parenchymal abnormality on cerebral imaging during the 
evolution, 2 ofthem presented the abnormalityon the first imaging. 
All patients also have a MRI duringthe acute phase of the disease, 
which was abnormal in 5 p'atients ( 50%). The most frequent findings 
are convexity SAH and ischemic stroke. 
In our institutions, non-invasive cerebro-vascular imaging was 
performed for all patients who presented thunderclap headaches 
and/or new neurological deficit. CT angiography or magnetic res-
onance angiography showed diffuse segmental vasoconstriction 
in all 10 patients. It was detectable on the first exam performed 
at a mean of 4 days after headaches onset. Cerebral vasospasm 
interested large and middle-size arteries in all cases. Anterior 
and posterior circulations were involved in 6 patients, cerebral 
vasospasms were bilateral in 9 patients, and only one patient 
presented an isolated middle cerebral artery vasoconstriction. 
The most frequent artery involved by vasoconstriction was the 
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middle cerebral artery (8 cases). One patient was known for AVM 
and aneurysm. 
3.6. Cerebrospinalfluid analysis (CSF) 
Lumbar puncture was performed in seven patients. CSF was 
abnormal in three patients, two had elevated CSF white blood 
cells and red blood cells, and one patient had elevated CSF protein 
level. lt was considered mainly as minor abnormalities attributed 
to underlying stroke or the SAH. There was no evidence for arte-
rial inflammation or infection. Blood analysis showed no significant 
abnormalities. Erythrocyte sedimentation rate and C-reactive pro-
tein level were normal in 90% of cases at admission. 
3.7. Treatment 
Al! precipitating factors were stopped including vaso-active 
drugs. AU patients known for hypertension were actively treated 
with anti-hypertensive drugs. No standard treatment was used 
in these 7 patients. Nimodipine by oral administration (30-60 mg 
every 4h adapted to blood pressure) was used in 3 patients for 
vaso-protection and vasospasm prevention. We could not found 
any correlation between the treatment and the clinical evolution 
in our series. 
3.8. Clinical outcome 
The mean duration of clinical follow-up was 10.2 months (range: 
0-28 months). First follow-up visit 6 weeks after the discharge was 
marked by disappearance ofheadache in al! but 2 cases (Fig. 2) who 
died at hospital during first weeks of the evolution. Two patients 
presented neurological sequelae: one patient had a dysphasia and 
the other had a homonymous hemianopia. No neurological deficit 
appeared after the discharge of patients. No recurrent thunder-
clap headaches occurred during the follow-up. However, 3 patients 
developed migraine, which responded to Iow-level analgesic drugs. 
Good clinical outcome (modified Rankin Score, mRS 0-2) was noted 
in 8 (80%) patients. The other 2 patients died and had, by de finition, 
a mRS at 6. AU patients were strongly advised to abstain from al! 
vaso-active drugs. 
3.9. Cases withfatal evolution 
The first case (patient 2) was a female, 68 years old, with 
migraine treated by sumatriptan who presented spontaneous 
thunderclap headache followed by right hemiparesis and Joss of 
consciousness. At admission, the patient presented a right hemi-
paresis with a Glasgow Coma scale at 6. After intubation and 
sedation for cerebral protection, we performed a CTA and a MRA, 
which showed an ischemia in the left anterior cerebral artery and 
left anterior choroidal artery territories. Severe vasoconstriction 
was also fin ding in the left carotid siphon and the leftA 1. The patient 
was then admitted to the intensive care unit for medical neuro-
reanimation. A OSA was performed the day after which confirmed 
severe vasospasm on the left side with hypoplasia of the segment 
Al on the right side. Oespite chemical and balloon angioplasty, no 
improvement of the cerebral perfusion was noted and the patient 
developed progressively a cerebral edema. Regarding the age, the 
neurological status at admission and the evolution of the imaging, 
we decided not to perform a bifrontal craniectomy and the patient 
died 4 days after her admission. No autopsy was performed. 
The second case (patient 3, Fig. 2) was a 53 years-old female 
who presented a right hemiparesis and thunderclap headache at 
admission without loss of consciousness. The first CT (Fig. 2a) 
showed fronto-parietal subarachnoid hemorrhage with cortical 
hematoma. OSA performed at day 1 (Fig. 2b and c) highlighted 
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Fig. 2. Neuro-imaging of the case 3. 53 years-old female presented at admission a right hemiparesis and thunderclap headache. The axial head CT (a) showed cortical SAH 
and parenchymal hematoma. Right carotid artery (b) and left vertebral artery (c) DSA with lateral views showed at day 1 diffuse vasoconstriction in large and middle-size 
arteries (arrowheads). Five days later, the patient developed a right lower limb paresis and became confused. Axial T2-MR imaging (d) showed the apparition of a new left 
side frontal hematoma. Cerebral OSA (e-f) performed 5 days after the admission highlighted the progression of diffuse cerebral vasoconstriction (arrowheads). Oespite the 
resolution ofvasospasm as showed on cerebral OSA (h and i) performed 12 days after the admission, the patient presented a diffuse cerebral edema (g) and died at day 13. 
diffuse vasoconstriction in large and middle-size arteries. Consid-
ering the diagnosis of drug-induced (cannabis) reversible cerebral 
vasoconstriction syndrome, we opted for a wait-and-see attitude. 
Five days after, the patient developed a right lower limb paresis 
and became confused. MR imaging (Fig. 2d) showed the apparition 
of a new left sided frontal hematoma. Cerebral OSA (Fig. 2e and 
f) performed 5 days after the admission highlighted the progres-
sion of diffuse cerebral vasoconstriction. Progressively, the level of 
conscious of the patient decreased des pite of the active treatment 
of cerebral vasospasm (intravenous nimodipine and chemother-
apy angioplasty) necessitating· intubation, sedation and intensive 
care unit hospitalization. Oespite the resolution of vasospasm 
seen on cerebral OSA (Fig. 2h and i) performed 12 days after 
the admission, the patient presented a diffuse cerebral edema 
(Fig. 2g) and died at day 13. The autopsy was performed and 
showed large infarcts in bath hemisphere with microclots and 
ischemic changes in different parts of the brain (hippocampus, cin-
gulate and insular regions ). Middle-size vascular changes have been 
noted as inflammatory processes, endothelial proliferation and 
apoptosis. 
3.1 O. Radiological evolution 
Ali surviving patients were controlled by MRA at 6 weeks, 3 
months and 6 months after the discharge. MRA confirmed the 
resolution of cerebral vasoconstriction syndrome. No recurrent 
RCVS occurred during the rest of the follow-up. Ali patients who 
had presented with convexity SAH had a resolution on follow-
up imaging. No secondary complication was noted by cerebral 
imaging. 
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3. 11. Factors of poor outcome 
Two patients (20%) died in the aftermath of the RCVS. Two others 
(20%) had neurological sequelae of the RCVS. We have not found any 
significant difference of evolution between secondary RCVS and 
idiopathie RCVS. The only two factors that could be correlated to 
the clinical outcome were the neurological status at admission and 
the presence of intraparenchymal abnormalities ( ischemic stroke, 
hematoma) in cerebral imaging. 
4. Discussion 
Reversible cerebral vasoconstriction syndrome is emerging as 
an important cause of stroke in patients younger than 60 years 
[1-3,6-9], Vasoconstriction syndromes remain poorly character-
ized and under-recognized mainly because of the lac!< of specific 
diagnostic tests or diagnostic criteria [ 1,2,6-9,39]. Misdiagnosis is 
frequent because the clinical, radiologie and angiographie abnor-
malities are often indistinguishable from conditions that cause 
irreversible arterial narrowing [24-26,29,32]. 
RCVS is considered an extremely rare syndrome [ 1,3,7-9]; how-
ever, the growing use of vaso-active drugs combined by more 
frequent use of non-invasive neurovascular imaging increase his 
incidence. 
The patho-physiology of this syndrome is not known but fac-
tors such as vaso-active drugs [9-21] and post-partum period 
[22,24,25,30-38] has been identified as precipitating factors. In 
our series, we identified a causative factor in 60% of pàtients 
which correlated with results found in other series in the litera-
ture. In a review published in 2009, Ducros et al. [6,7] evaluated 
the rate of secondary RCVS as 25-60% of cases. The more frequent 
vasoactive drugs found are selective serotonin reuptake inhibitors 
[1-3,6-11,13], cannabis [1,3,6-9], ectasy [3,6,9] and sumatriptan 
[1-3]. 
Most reported cases have been young and predominantly 
females [1,3,5-9]. Thunderclap headaches, which are often asso-
ciated with nausea and vomiting, are typical at onset. A history of 
migraine [6,8,12,16], pregnancy [22,24,25,30-38] or recent expo-
sure to vaso-active [ 9-21] drugs is usually present. The thunderclap 
headaches can be exacerbated byValsalva maneuvers and can recur 
for weeks [1-3,5-9,14]. Focal neurological deficits can develop 
from stroke due to severe vasoconstriction [5-9]. Generalized 
seizures could occur at the onset or within the first few days 
[ 6-9, 12]. Persistent focal deficits although infrequent, are usually 
due to a hematoma or infarction [ 1,3,6-8]. Our series is atypical 
because it con tains two cases of persistent focal deficit due to intra-
parenchymal hemorrhage. An isolated case of fatal evolution after 
postpartum cerebral angiopathy had been described by Williams 
et al. [41] and could be compared with the fatal cases ofour series. 
The diagnosis of RCVS is based on the presence of segmen-
tal arterial narrowing and dilatation on invasive or non-invasive 
cerebral angiography [3,6]. Cerebral CT was generally the first 
investigation [6]. In the literature, 28-80% of patients presented 
abnormalities on the first CT including convexity subarachnoid 
hemorrhage [1,4,25-28] (12-34%), ischemic stroke [7-9] (9-39%) 
and intracerebral hematoma [7,8] (5-20%). Cerebral MRI could also 
be an alternative choice to diagnose RCVS but most reports showed 
an increased sensibility of the MRI between day 5 and 8 after the 
onset of headaches [6-9]. We recommend performing a cerebral 
CT scan the first day and cerebral MRI a few days after. Vascular 
imaging could be performed by Œf or MRI, the use of conventional 
angiography could be reserved for particular cases. 
Most patients with RCVS recovered completely within days 
[1,6]. Cases with minor disabilities were described in the lit-
erature [3,6] (visual field deficit, mild hemiparesis). Fulminant 
vasoconstriction resulting in progressive symptoms or de a th, as our 
2 cases, has been reported in exceptional frequency [38 ], Physicians 
had to remember that such evolution could happen and to identify 
all factors of poor prognosis (neurological status at admission, the 
presence of intraparenchymal abnormalities ). 
There was no specific treatment established for RCVS even if a lot 
ofvasodilator treatments have been tried. Calcium channel block-
ers such as nimodipine [1-3,6], magnesium [5-9], and steroids 
have been used without clear benefit. Balloon angioplasty has been 
used in patients with progressive neurological deficit secondary 
to ischemic stroke [6]. Progressive clinical improvement occurs 
in most patients however; some patients could keep long-term 
deficits for which specific therapy is extremely useful. 
5. Conclusion 
Reversible cerebral vasoconstriction syndrome is more fre-
quent than previously thought. Our results highlight that RCVS 
could present a catastrophic neurological evolution and also they 
emphasize the need of considering the presence of parenchymal 
abnormalities at admission as an independent prognostic factor. 
Our study is limited by its retrospective nature and by the small 
number of patients. Larger series, even if it is difficult to conduct 
regarding the rarity of the pathology, will permit to determine 
which treatment could prevent poor outcomes. 
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